Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I - Raymond Y. Wang, Afshin Aminian, Michael F. McEntee, Shih-Hsin Kan, Calogera M. Simonaro, William C. Lamanna, Roger Lawrence, N. Matthew Ellinwood, N. Matthew Ellinwood, Catalina Guerra, Steven Q. Le, Patricia I. Dickson, Jeffrey D. Esko - Dissemin

Language
Login

Published in

Elsevier, Molecular Genetics and Metabolism, 4(112), p. 286-293

DOI: 10.1016/j.ymgme.2014.05.015

Links

Tools

Export citation

Search in Google Scholar

Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I

Journal article published in 2014 by Raymond Y. Wang, Afshin Aminian, Michael F. McEntee, Shih-Hsin Kan, Calogera M. Simonaro, William C. Lamanna, Roger Lawrence, N. Matthew Ellinwood, N. Matthew Ellinwood, Catalina Guerra, Steven Q. Le, Patricia I. Dickson, Jeffrey D. Esko

This paper is available in a repository.

This paper is available in a repository.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO